A kind of external medicine for treating rheumatoid arthritis and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for rheumatoid arthritis and external use of drugs, applied in the field of medicine, can solve the problems of pigmentation in the affected area, blistering in the affected area, and difficult for patients to accept.
Inactive Publication Date: 2018-04-20
THE AFFILIATED HOSPITAL OF SHANDONG UNIV OF TCM
View PDF3 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The inventor found in clinical practice that although the prescription is better for treating skin diseases, the prescription contains strong irritating white mustard seeds, dried ginger, pepper, and garlic, and patients are prone to blisters in the affected area and tissue fluid when they are used externally. The phenomenon of outflow, and the affected area where the foaming tissue fluid outflows is easy to leave pigmentation, which is not easy for patients to accept
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
[0024] Preparation method: (1) Add wild watermelon seedlings into pure grain liquor, seal and soak for 30 days, filter, and use the filtrate for later use;
[0025] (2) Add ancestral hemp, borneol, golden snake, Wujiapi, atractylodes, musk, notopterygium, solitary, asarum, earthworm, and licorice to the filtrate obtained in step (1), seal it for more than 30 days, and filter, that is have to.
[0028] Preparation method: (1) Add wild watermelon seedlings into pure grain liquor, seal and soak for 30 days, filter, and use the filtrate for later use;
[0029] (2) Add ancestral hemp, borneol, golden snake, Wujiapi, atractylodes, musk, notopterygium, solitary, asarum, earthworm, and licorice to the filtrate obtained in step (1), seal it for more than 30 days, and filter, that is have to.
Embodiment 3
[0031] Prescription: 5300g of wild watermelon seedlings, 1800g of Zushima, 1300g of borneol, 18g of money snake, 2100g of Wujiapi, 1900g of herb, 9-14g of musk, 2000g of notopterygium, 1800g of solitary, 140g of asarum, 22g of earthworm, 95g of licorice, pure Grain liquor 17000ml.
[0032] Preparation method: (1) Add wild watermelon seedlings into pure grain liquor, seal and soak for 30 days, filter, and use the filtrate for later use;
[0033](2) Add ancestral hemp, borneol, golden snake, Wujiapi, herb, musk, Qianghuo, Duhuo, Asarum, earthworm, and licorice to the filtrate obtained in step (1), seal it for more than 30 days, and filter it, that is have to.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention belongs to the technical field of medicine, and particularly relates to an external used drug for treating rheumatic arthritis and a preparing method thereof. The medicine is prepared from, by weight, 4800-5500 g of Hibiscus trionum L., 1500-2500 g of Bark of Girald Daphne, 960-1300 g of borneol, 15-30 g of bungarus parvus, 1500-2300 g of cortex acanthopanacis, 1800-2200 g of rhizoma atractylodis, 8-15 g of musk, 1500-2200 of Incised notopterygium, 1500-2800 g of Heracleum hemsleyanum, 100-150 g of asarum sieboldii Miq., 20-30 g of earthworm, 80-100 g of glycyrrhiza uralensis fisch, and 14000-18000 ml of pure grain baijiu. The drug can be used externally for treating rheumatic arthritis, and has the advantages of being high in cure rate, high in total effective rate, good in prognosis, and low in recurrence rate. No untoward effects occur during treatment of rheumatic arthritis through the drug, toxic and side effects during treatment through oral drugs are avoided, and the external used drug is convenient and safe. Therefore, patients are readily to accept the external used drug for treating rheumatic arthritis.
Description
technical field [0001] The invention belongs to the technical field of medicines, and in particular relates to a medicine for external use for treating rheumatoid arthritis and a preparation method thereof. Background technique [0002] Rheumatoid arthritis is one of the more common clinical diseases, which is a common acute or chronic inflammation of connective tissue. Can be recurrent and involve the heart. Clinically, it is characterized by migratory soreness, heaviness, and pain in joints and muscles, and the onset is mostly acute fever and arthralgia. Affected joints are mostly large joints such as knees, ankles, shoulders, elbows, and wrists. It is common to transfer from one joint to another. The local lesion is red, swollen, hot, and severe pain. Some patients also have several joints at the same time. Acute inflammation Usually subsided in 2-4 weeks without sequelae, but often recurring. [0003] The current treatment methods include: 1. Traditional Chinese medic...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more